Haemonetics Corp
NYSE:HAE

Watchlist Manager
Haemonetics Corp Logo
Haemonetics Corp
NYSE:HAE
Watchlist
Price: 92.11 USD 0.36%
Market Cap: 4.7B USD
Have any thoughts about
Haemonetics Corp?
Write Note

Net Margin
Haemonetics Corp

9.1%
Current
8%
Average
2.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
9.1%
=
Net Income
123.8m
/
Revenue
1.4B

Net Margin Across Competitors

Country US
Market Cap 4.6B USD
Net Margin
9%
Country JP
Market Cap 7T JPY
Net Margin
24%
Country CH
Market Cap 37.8B CHF
Net Margin
11%
Country DK
Market Cap 205.9B DKK
Net Margin
19%
Country US
Market Cap 16B USD
Net Margin
11%
Country CN
Market Cap 53.9B CNY
Net Margin
42%
Country CA
Market Cap 7B USD
Net Margin
-8%
Country UK
Market Cap 5.3B GBP
Net Margin
7%
Country CH
Market Cap 5.2B CHF
Net Margin
14%
Country US
Market Cap 5.9B USD
Net Margin
9%
Country KR
Market Cap 8T KRW
Net Margin
-472%

Profitability Report

View the profitability report to see the full profitability analysis for Haemonetics Corp.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
9.1%
=
Net Income
123.8m
/
Revenue
1.4B
What is the Net Margin of Haemonetics Corp?

Based on Haemonetics Corp's most recent financial statements, the company has Net Margin of 9.1%.